CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Por um escritor misterioso
Last updated 02 junho 2024
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
IJMS, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Mechanisms of SARS-CoV-2 entry into cells
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
IJMS, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Cells, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Viruses, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Biology, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Frontiers Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
IJMS, Free Full-Text
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
PDF) CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Frontiers Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS- CoV-2

© 2014-2024 importacioneskab.com. All rights reserved.